Ribavirin in chronic hepatitis C: past and future

Expert Rev Anti Infect Ther. 2009 Apr;7(3):249-53. doi: 10.1586/eri.09.5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents* / administration & dosage
  • Antiviral Agents* / adverse effects
  • Antiviral Agents* / therapeutic use
  • Drug Monitoring / methods
  • Drug Synergism
  • Drug Therapy, Combination
  • Hepacivirus / drug effects*
  • Hepacivirus / genetics
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / virology
  • Humans
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use
  • Polyethylene Glycols / administration & dosage
  • Polyethylene Glycols / therapeutic use
  • Ribavirin* / administration & dosage
  • Ribavirin* / adverse effects
  • Ribavirin* / therapeutic use
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Polyethylene Glycols
  • Ribavirin